Member Info for ForFXSake

At timestamp 14:00 in the Proactive. He also strangely starts taking about the time researching inhalation as not being wasted. I don't think they said it out loud but it sounded to me like inhalation was going on the back burner in favour of research involving some other delivery method at potentially lower doses.

If they are not progressing inhalation then I wonder what other delivery method they are contemplating?

"now its every social media platform filled with air heads and agenda merchants"

Says you! Laughable.

I do accept others opinions. As I have stated many times before, I welcome them. I also never tell other posters that they should see things as I see them.

"If I was fed up I would take my losses and move on and not spend my time making a negative out of positive news …"

In the same way, I suppose, that if you're fed up with people emhaving a different opinion to yours, you could always move on then too.

I'm tired of the blather, Filter...and of lining the pockets of our partner's shareholders while doing nothing for our own.

I'll take a look at it.

However, statements such as: "These studies will be funded from the Company's existing cash position .." do not equate to: "The studies will not impose an additional financial burden".

They haven't made that clear in the RNS so my assumption is worst case.

"The Company's NXP002 poster sessions were well-attended by, amongst others, potential licensing partners..."

Not sure that wording constitutes any kind of initiation with potential licensees, it just says they were there.

From what I can see, the only winners at the moment are the CRO and whoever has a stake in them.

Qureight eh?

Small world!

It's an additional cost on top of what we've already spent on the abandoned testing strategy. My assumption is that we'll have to run the full new testing strategy from scratch instead of just being able to start from where we left off.

They could always clarify that though.

So they're giving up pushing NXP002 as a blockbuster in it's own right to focus on marketing it as a top-up drug to existing standard of care? They're also turning their back on the testing strategy they originally chose in favour of a 3D (AI?) Model:

"However, the pre-clinical inhalation disease model chosen has proven to be complex, and unlike previous studies in human IPF tissue, it continues to be challenging to achieve consistent and reproducible results, which will likely increase in the study of combination therapies, which are now clearly required given the clinical trends intelligence gathered at the ERS . As a consequence, the Company is stopping its current study and will initiate studies in 3D human IPF lung tissue using a disease and species relevant model that is now available commercially via a CRO"

Another change of direction along increased costs from a new CRO? No mention of who the CRO is.

Nothing more than the usual pump n dump in the absence of news.

You call people foolish for risking their money here and yet you are willing to punt on blips while you tell us all that it's about to go bust!

If you're so savvy then why are you going against your own advice? There are plenty of safer bets out there.

Laughable!

" Then we can ride this train one more time before it hits the wall."

Aaaah! I think I get it now, so your posts are just to accentuate the dump in readiness for the next pump?

I really don't know what to say! You're just too kind

Have they ever bought any shares Thompi?

LOL!

:(

For all those chomping at the bit for an interview, here's one they prepared earlier...3 years ago, actually.

https://m.youtube.com/watch?v=uBEFykuQHQI

You could probably release the same guff today and it would be fairly accurate except, of course, for the fact that we are no longer in the cannabinoid arena, no longer have a meaningful hold on CINV and are missing a fair few of the star players on the board. It was interesting to hear how our royalties on the cannabinoid stuff was going to be 20%, yet we only ended with a paltry £2m for the Oxilio deal.

Note at the end how the sell off the company has always been the plan....the big question is who are they intending to sell it to and will they have left us in any position to negotiate if/when it comes about?

PS. They also kept stating in the viedo how these things could be developed really fast. Funny how everything now seems to "just take time".

"....or there are questions they don’t want asked"

Indeed Mars. Indeed!

Anyone surprised that it has been so quiet since Dr Gooding returned? There was a time, before he left, when you couldn't keep him off social media. His enthusiasm was uplifting.

Surely, there must be something to talk about from the list below:

- The Oxilio partnership
- NXP004's progress and interest from AZ
- The NXP002 business development activities that Dr. Gooding himself was hired to undertake?